The Allergy Vaccine market was valued at USD 1.43 Billion in 2024 and is expected to reach USD 3.38 Billion by 2032, growing at a CAGR of 11.32% (2024-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.